Entera Bio Ltd reports results for the quarter ended in March - Earnings Summary

Entera Bio

20/05/2021 15:46

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted loss
of 11 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 12 cents per
share.
* Revenue rose 273.8% to $157.00 thousand from a year ago; 
analysts expected $91.00 thousand. 
* Entera Bio Ltd's reported EPS for the quarter was a loss of 43
cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Entera Bio Ltd shares had fallen by 21.3% this quarter and
gained 177.8% so far this year.
* The company reported a quarterly loss of $9.49 million.
* Wall Street's median 12-month price target for Entera Bio Ltd
is $11.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 20 at 02:46 p.m. GMT.
​All figures in US dollars